Showing results (1-10 of 2,920) with videos related to
Sort By:
Pageof 292
The Oncologist|September 2, 2017
Next-Generation Sequencing for Patients with Sarcoma: A Single Center ExperienceGregory M Cote, Jie He, Edwin ChoyCurrent Treatment Options in Oncology|June 11, 2013
Role of epigenetic modulation for the treatment of sarcomaGregory M Cote, Edwin ChoyHematology/Oncology Clinics of North America|October 8, 2013
Update in treatment and targets in Ewing sarcomaGregory M Cote, Edwin ChoyOncoimmunology|January 23, 2015
Targeting programmed cell death ligand 1 in osteosarcoma: an auto-commentary on therapeutic potentialJacson K Shen, Gregory M Cote, Edwin Choy, et al.The Oncologist|October 16, 2023
A Rare Presentation of Aggressive Renal Cell Carcinoma and the Utility of Early Molecular Testing in Rapidly Progressing Malignancies: A Case ReportDaniel E McLoughlin, Nicholas Chevalier, Edwin Choy, et al.Scientific Reports|April 30, 2016
Targeting EZH2-mediated methylation of H3K27 inhibits proliferation and migration of Synovial Sarcoma in vitroJacson K Shen, Gregory M Cote, Yan Gao, et al.The American Journal of Surgical Pathology|November 1, 2018
Spindle and Round Cell Sarcoma With EWSR1-PATZ1 Gene Fusion: A Sarcoma With Polyphenotypic DifferentiationAbhijit Chougule, Martin S Taylor, Valentina Nardi, et al.Current Reviews in Musculoskeletal Medicine|October 11, 2015
Rank ligand as a target in musculoskeletal neoplasmsGregory M CoteInternational Journal of Radiation Oncology, Biology, Physics|February 8, 2018
Secondary Acute Leukemia in Sarcoma Patients: A Population-Based StudyNina N Sanford, Allison M Martin, Andrew M Brunner, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2024
Safety and Efficacy of the Combination Lurbinectedin plus Doxorubicin from a Phase 1b Trial in Patients with Advanced/Metastatic Soft-Tissue SarcomaGregory M Cote, Candace L Haddox, Edwin Choy, et al.Pageof 292